138 related articles for article (PubMed ID: 29228743)
21. Prognostic role of fibroblast growth factor receptor 2 in human solid tumors: A systematic review and meta-analysis.
Liu G; Xiong D; Xiao R; Huang Z
Tumour Biol; 2017 Jun; 39(6):1010428317707424. PubMed ID: 28618942
[TBL] [Abstract][Full Text] [Related]
22. The prognostic role of Gas6/Axl axis in solid malignancies: a meta-analysis and literature review.
Zhang S; Xu XS; Yang JX; Guo JH; Chao TF; Tong Y
Onco Targets Ther; 2018; 11():509-519. PubMed ID: 29416351
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of Midkine expression in patients with solid tumors: a systematic review and meta-analysis.
Zhang L; Song X; Shao Y; Wu C; Jiang J
Oncotarget; 2018 May; 9(37):24821-24829. PubMed ID: 29872508
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of CD146 in solid tumor: A Systematic Review and Meta-analysis.
Zeng P; Li H; Lu PH; Zhou LN; Tang M; Liu CY; Chen MB
Sci Rep; 2017 Jun; 7(1):4223. PubMed ID: 28652617
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of programed death ligand 1 in patients with solid tumors: A meta-analysis.
Jin Y; Zhao J; Shi X; Yu X
J Cancer Res Ther; 2015 Aug; 11 Suppl 1():C38-43. PubMed ID: 26323922
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of Ezrin in solid tumors: a meta-analysis of the literature.
Han K; Qi W; Gan Z; Shen Z; Yao Y; Min D
PLoS One; 2013; 8(7):e68527. PubMed ID: 23894313
[TBL] [Abstract][Full Text] [Related]
27. Meta-analysis of the prognostic value of lncRNA ZFAS1 in patients with solid tumors.
Song W; Tian C; Zhang RJ; Zou SB; Wang K
Oncotarget; 2017 Oct; 8(52):90301-90307. PubMed ID: 29163829
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of DEK gene is correlated with poor prognosis in hepatocellular carcinoma.
Yi HC; Liu YL; You P; Pan JS; Zhou JY; Liu ZJ; Zhang ZY
Mol Med Rep; 2015 Feb; 11(2):1318-23. PubMed ID: 25351213
[TBL] [Abstract][Full Text] [Related]
29. The prognostic role of controlling nutritional status scores in patients with solid tumors.
Liang RF; Li JH; Li M; Yang Y; Liu YH
Clin Chim Acta; 2017 Nov; 474():155-158. PubMed ID: 28964833
[TBL] [Abstract][Full Text] [Related]
30. B7-H4 as an independent prognostic indicator of cancer patients: a meta-analysis.
Meng Z; Wang F; Zhang Y; Li S; Wu H
Oncotarget; 2017 Sep; 8(40):68825-68836. PubMed ID: 28978159
[TBL] [Abstract][Full Text] [Related]
31. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
[TBL] [Abstract][Full Text] [Related]
32. C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis.
Ren JL; Wu HF; Wang WJ; Hu GM; Gu B; Zhang M; Wang YX
Panminerva Med; 2017 Mar; 59(1):97-106. PubMed ID: 27636117
[TBL] [Abstract][Full Text] [Related]
33. Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis.
Liu F; Qi L; Liu B; Liu J; Zhang H; Che D; Cao J; Shen J; Geng J; Bi Y; Ye L; Pan B; Yu Y
PLoS One; 2015; 10(3):e0116683. PubMed ID: 25775399
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of EphA2 in various human carcinomas: a meta-analysis of 23 related studies.
Shen W; Xi H; Zhang K; Cui J; Li J; Wang N; Wei B; Chen L
Growth Factors; 2014 Dec; 32(6):247-53. PubMed ID: 25418013
[TBL] [Abstract][Full Text] [Related]
35. Prognostic role of intratumoral IL-17A expression by immunohistochemistry in solid tumors: a meta-analysis.
Wang S; Li Z; Hu G
Oncotarget; 2017 Sep; 8(39):66382-66391. PubMed ID: 29029520
[TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA CCAT2 can predict metastasis and poor prognosis: A meta-analysis.
Fan YH; Fang H; Ji CX; Xie H; Xiao B; Zhu XG
Clin Chim Acta; 2017 Mar; 466():120-126. PubMed ID: 28089750
[TBL] [Abstract][Full Text] [Related]
37. CXCR4--A Prognostic and Clinicopathological Biomarker for Pancreatic Ductal Adenocarcinoma: A Meta-Analysis.
Krieg A; Riemer JC; Telan LA; Gabbert HE; Knoefel WT
PLoS One; 2015; 10(6):e0130192. PubMed ID: 26091099
[TBL] [Abstract][Full Text] [Related]
38. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis.
Wang J; Ye C; Chen C; Xiong H; Xie B; Zhou J; Chen Y; Zheng S; Wang L
Oncotarget; 2017 Mar; 8(10):16875-16886. PubMed ID: 28187435
[TBL] [Abstract][Full Text] [Related]
39. The prognostic implication of slug in all tumour patients - a systematic meta-analysis.
Huang C; Zhang P; Zhang D; Weng X
Eur J Clin Invest; 2016 May; 46(5):398-407. PubMed ID: 26919035
[TBL] [Abstract][Full Text] [Related]
40. Promoter methylation of BRCA1 in the prognosis of breast cancer: a meta-analysis.
Wu L; Wang F; Xu R; Zhang S; Peng X; Feng Y; Wang J; Lu C
Breast Cancer Res Treat; 2013 Dec; 142(3):619-27. PubMed ID: 24258259
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
